UCB's Global Corporate Website
Welcome to UCB in the United States


Find U.S. news and updates from UCB, a global biopharmaceutical company focused on creating value for people living with severe diseases, such as epilepsy, Parkinson’s disease, psoriasis, osteoporosis, myasthenia gravis,  rheumatoid arthritis, psoriatic arthritis, non-radiographic axial spondyloarthritis, and more. 

Spotlight Story

No results



UCB U.S. News

Bimekizumab Phase 3 Data in Hidradenitis Suppurativa Show Clinically Meaningful, Deep and…

Read More

Exploring the future of dermatology at AAD 2023

Read More

You Speak, We Listen: How Community Voices Drive Our Work in HS

Read More

Twitter Feed

For More Information